Ipsen and Inspiration team up for haemophilia franchise
This article was originally published in Scrip
Executive Summary
The French firm Ipsen and the US-based Inspiration Biopharmaceuticals have agreed to form a haemophilia franchise which they hope will generate worldwide sales of more than $1 billion by 2020.